AstraZeneca Chief Executive David Brennan is to step down on June 1 in an abrupt exit after …
Tag:
David Brennan
-
-
European shares markets moved mostly higher on Thursday, as well-received results from heavyweight companies supported indexes, while …
-
AstraZeneca Plc (AZN) agreed to buy Ardea Biosciences Inc. (RDEA) for $1.26 billion to add experimental gout …